Condition
Single Ventricle Heart Disease
Total Trials
6
Recruiting
2
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
P 2 (1)
P 3 (3)
Trial Status
Completed3
Recruiting2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06762964Phase 2Recruiting
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
NCT05199857Not ApplicableActive Not Recruiting
WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program
NCT05918211Phase 3RecruitingPrimary
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
NCT03430583Phase 3CompletedPrimary
Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness
NCT02741115Phase 3CompletedPrimary
Fontan Udenafil Exercise Longitudinal Assessment Trial
NCT03687008Not ApplicableCompletedPrimary
Cognitive Intervention to Improve Working Memory
Showing all 6 trials